Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
Year: 2014
Type: article
Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
Funders: AstraZeneca, Imperial College London
OpenAlex ID: W2153443504
